PRISM BioLab Co.,LTD (206A.T)
JPY 292.0
(-1.68%)
JPY 292.0
(-1.68%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -488.13 Million JPY | -735.35% |
| 2022 | 67.89 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -233.19 Million JPY | 0.0% |
| 2023 FY | - JPY | -735.35% |
| 2022 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 958.1 Million JPY | 150.948% |
| GNI Group Ltd. | 14.48 Billion JPY | 103.369% |
| Linical Co., Ltd. | 1.24 Billion JPY | 139.137% |
| Trans Genic Inc. | 240.95 Million JPY | 302.585% |
| MEDINET Co., Ltd. | -1.35 Billion JPY | 63.998% |
| Soiken Holdings Inc. | -583.2 Million JPY | 16.302% |
| Cytori Cell Research Institute, Inc. | -603.09 Million JPY | 19.062% |
| AnGes, Inc. | -8.86 Billion JPY | 94.491% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 62.028% |
| Nxera Pharma Co., Ltd. | -7.39 Billion JPY | 93.403% |
| Immuno-Biological Laboratories Co., Ltd. | 128.1 Million JPY | 481.035% |
| NanoCarrier Co., Ltd. | -863 Million JPY | 43.438% |
| Carna Biosciences, Inc. | -1.09 Billion JPY | 55.29% |
| CanBas Co., Ltd. | 53.65 Million JPY | 1009.828% |
| D. Western Therapeutics Institute, Inc. | -775.59 Million JPY | 37.063% |
| RaQualia Pharma Inc. | -111.8 Million JPY | -336.608% |
| Chiome Bioscience Inc. | -1.21 Billion JPY | 59.716% |
| Kidswell Bio Corporation | -1.38 Billion JPY | 64.649% |
| PeptiDream Inc. | 7.37 Billion JPY | 106.618% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 74.704% |
| Ribomic Inc. | -1.01 Billion JPY | 51.791% |
| SanBio Company Limited | -4.52 Billion JPY | 89.213% |
| Healios K.K. | -3 Billion JPY | 83.767% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 58.129% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 64.96% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 65.183% |
| StemRIM | -2.03 Billion JPY | 75.978% |
| CellSource Co., Ltd. | 1.3 Billion JPY | 137.364% |
| FunPep Company Limited | -952 Million JPY | 48.726% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 45.077% |
| Stella Pharma Corporation | -723.85 Million JPY | 32.565% |
| TMS Co., Ltd. | -937 Million JPY | 47.905% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 37.047% |
| Cuorips Inc. | -518 Million JPY | 5.766% |
| K Pharma,Inc. | 366.05 Million JPY | 233.348% |
| Takara Bio Inc. | 8.02 Billion JPY | 106.083% |
| ReproCELL Incorporated | 8.24 Million JPY | 6020.34% |
| PhoenixBio Co., Ltd. | 87.93 Million JPY | 655.087% |
| StemCell Institute Inc. | 534.35 Million JPY | 191.35% |
| Japan Tissue Engineering Co., Ltd. | 244.81 Million JPY | 299.389% |
| CellSeed Inc. | -836.51 Million JPY | 41.647% |